Alert
Injectable Silicone for Body Contouring and Enhancement: FDA Safety Communication – FDA Warns Against Use
This is a reprint of an FDA Alert. [Posted 11/14/2017] AUDIENCE: Patient, Plastic Surgery, Dermatology, Surgery ISSUE: The FDA is alerting the public and health care providers that injectable silicone is not approved to enhance or augment the body. Such use can lead to ongoing pain, infections, and serious injuries, such as scarring and permanent…
[...]Hardcore Formulations Issues Voluntary Nationwide Recall of Ultra-Sten and D-Zine Capsules Due to Labeling that it Contains Anabolic Steroids
June 29, 2017 This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. For Immediate Release Contact Consumers sales@hardcoreformulations.com 1-855-773-6826 San Marcos, TX, Hardcore Formulations is…
[...]A&H Focal Inc. Issues Nationwide Recall of 21 Products Marketed as Dietary Supplements & One Cosmetic Product Due to Undeclared Drug Ingredients
This is a reprint of an FDA Alert. March 7, 2017 Contact Consumers Henry Choo: (646)327-8522 A&H Focal Inc. is voluntarily recalling all lots of the following products because many of these products have been historically tested by the FDA and found to contain PDE-5 Inhibitors (i.e. sildenafil, tadalafil, vardenafil, etc.) which is the active…
[...]FDA Alert: Kingsway Trading Inc. Recalls “Xanthium & Siler Combo (Bi Yan Pian) Dietary Supplement” because it Contains Banned Ephedra Alkaloids
This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. For Immediate Release February 7, 2017 Contact Consumers (718)366-2300 Kingsway Trading Inc. of Brooklyn, NY is…
[...]Love My Tru Body Issues Voluntary Nationwide Recall of Skinny Bee Diet Due To Presence of Undeclared Sibutramine, Desmethylsibutramine and/Phenolphthalein
This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. For Immediate Release November 8, 2016 Contact Consumers Sharon Demps lovemytrubody@yahoo.com (800) 540-7515 Company Announcement McDonough,…
[...]Ton Shen Health Recalls “DHZC-2 Tablet” Because of Possible Health Risk
This is a reprint of an FDA Alert. For Immediate Release August 11, 2016 Contact Consumers Ton Shen Health 1-312-842-2775 When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. Ton Shen Health of…
[...]FDA Alert: Dream Body Weight Loss Issues Voluntary Nationwide Recall of 3 Products Due to Undeclared Sibutramine
This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. For Immediate Release July 1, 2016 Contact Consumers Dream Body Weight Loss websales@dreambodyweightloss.com (888)882-7612 Grand Prairie,…
[...]FDA Alert: The Body Shot Bar Issues Voluntary Nationwide Recall of Step 2 Due to Undeclared Sibutramine
This is a reprint of an FDA Alert. Company Announcement When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. For Immediate Release: June 7, 2016 Contact Consumers: thebodyshotbarinfo@yahoo.com, (910)-849-3348 Media: Tiffany Braswell (910)-849-3348 The Body Shot Bar is…
[...]Beware of Illegally Marketed Diabetes Treatments
This is a reprint of an FDA Alert. En Español As the number of people diagnosed with diabetes continues to grow, illegally marketed products promising to prevent, treat, and even cure diabetes are flooding the marketplace. The U.S. Food and Drug Administration (FDA) is advising consumers not to use such products—for many reasons. For example,…
[...]FDA advises health care professionals that counterfeit BiCNU has been discovered in some foreign countries
This is a reprint of an FDA Alert. [05/12/2016] The FDA is informing health care professionals that a counterfeit version of the FDA approved cancer drug, BiCNU (carmustine for injection) 100 mg, has been detected in some foreign countries. There is no indication at this time that counterfeit BiCNU has entered the legitimate U.S. drug…
[...]